Correction

This article refers to:

Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland

Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland

I Koskivirta, J Ruotsalainen, S Kurki, P Lakkakorpi, H Salminen-Mankonen, L Pirilä, R Harvima and A Palomäki

Scandinavian Journal of Rheumatology

http://dx.doi.org/10.1080/03009742.2022.2151109

When it was first published online, line ‘Charlson comorbidity score, mean ± sd’ in Table 1 contained two numerical errors.

The correct line in Table 1 should read as follows:

Charlson Comorbidity score, mean (SD) 0.63 (0.94) 0.71 (0.92) 0.54 (0.85) 0.056 <0.001